Danny's inspiring survival story
30 May 2020
Danny Strosberg started to feel something was wrong when he noticed constant dizziness, daily headaches, and started to lose his vocabulary.
That’s when a CT scan revealed an egg-sized melanoma in his brain.
Danny underwent surgery to remove the tumour followed by six months of treatment. After a number of other tumours appeared throughout his body, he was placed on an immunotherapy clinical trial. It proved to be life saving.
Thanks to generous supporters, melanoma research has come so far. But we still have a long way to go. Our focus remains on achieving zero deaths from melanoma - a goal we believe we can reach in our lifetime.
“I had a complete response within about six months. All of my tumours disappeared.” Danny
Danny proudly calls himself a melanoma survivor. More than ever, he appreciates life, his friends and loved ones. He loves surfing and spending precious time with his wife Lisa and teenage daughter Gabby.
For patients like Danny, whose melanoma has spread to organs like their brain or lungs, clinical trials of new treatments are giving them a second chance at life.
Any life lost to melanoma is one too many. With your support, we will continue our research effort until we achieve our mission of zero deaths from melanoma.
Danny appreciates how immunotherapy treatment saved his life. Now he wants to give other patients the hope to watch their families grow up.
“The advances in melanoma research are being translated to other cancers, and the potential benefits are limitless. I literally owe my life to the work that is being done at MIA.” Danny
We hope Danny’s story inspires you to consider sending a donation.
Your gift could help fund a game-changing new treatment so that – one day very soon – no-one will die from melanoma.
Click below to donate securely via credit card, PayPal or direct deposit. Gifts over $2 are tax-deductible.
MIA's dermatologist shares her knowledge with GPs on debunking myths and controversies on sunscreen.
Shannan Ponton thought he was invincible – he wasn’t. But his melanoma battle ended up saving more than his own life.
Researchers have demonstrated that immunotherapy is highly effective in treating a rare form of melanoma – a result that is surprising due to the nature of the tumour.
Innovation is helping to prevent melanoma developing in the first place.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.